NeuroVasx, Inc. Company Profile
To develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.NeuroVasx, Inc. was founded in 1997 to produce unique diagnostic and therapeutic devices for the neurovascular embolization market. Utilizing unique materials, NeuroVasx's products are intended for the treatment of intracranial aneurysms that, because of their morphology, location, or patients general medical condition, are considered high risk for management by traditional operative techniques.The development of our paramount product, cPAX ™, commenced in 2001 with a grant furnished by the National Institute of Health. The objective of cPAX ™ is to provide a more viable and cost effective method for treating the estimated 320,000 cerebral aneurysms present worldwide. Please click TECHNOLOGY for further information.
7351 Kirkwood Lane North, Suite 112
United States of America
Phone: (763) 315.0013
Fax: (763) 315.0966
Drugs and Medications
To develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.NeuroVasx, Inc. was founded in 1997 to produce unique diagnostic and...
More Information about "NeuroVasx, Inc." on BioPortfolio
We have published hundreds of NeuroVasx, Inc. news stories on BioPortfolio along with dozens of NeuroVasx, Inc. Clinical Trials and PubMed Articles about NeuroVasx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroVasx, Inc. Companies in our database. You can also find out about relevant NeuroVasx, Inc. Drugs and Medications on this site too.